Negotiating the boundary between medicine and consumer culture: Online marketing of nutrigenetic tests

Genomics researchers and policy makers have accused nutrigenetic testing companies—which provide DNA-based nutritional advice online—of misleading the public. The UK and USA regulation of the tests has hinged on whether they are classed as “medical” devices, and alternative regulatory categories for “lifestyle” and less-serious genetic tests have been proposed. This article presents the findings of a qualitative thematic analysis of the webpages of nine nutrigenetic testing companies. We argue that the companies, mirroring and negotiating the regulatory debates, were creating a new social space for products between medicine and consumer culture. This space was articulated through three themes: (i) how “genes” and tests were framed, (ii) how the individual was imagined vis a vis health information, and (iii) the advice and treatments offered. The themes mapped onto four frames or models for genetic testing: (i) clinical genetics, (ii) medicine, (iii) intermediate, and (iv) lifestyle. We suggest that the genomics researchers and policy makers appeared to perform what Gieryn (Gieryn, T.F. (1983). Boundary-work and the demarcation of science from non-science: strains and interests in professional ideologies of scientists. American Sociological Review, 48, 781–795.) has termed “boundary work”, i.e., to delegitimize the tests as outside proper medicine and science. Yet, they legitimated them, though in a different way, by defining them as lifestyle, and we contend that the transformation of the boundaries of science into a creation of such hybrid or compromise categories is symptomatic of current historical times. Social scientists studying medicine have referred to the emergence of “lifestyle” products. This article contributes to this literature by examining the historical, regulatory and marketing processes through which certain goods and services become defined this way.

[1]  M. Gibbons,et al.  Re-Thinking Science: Knowledge and the Public in an Age of Uncertainty , 2003 .

[2]  Jay L. Lemke,et al.  Travels in hypermodality , 2002 .

[3]  P. Conrad,et al.  Medicalization, markets and consumers. , 2004, Journal of health and social behavior.

[4]  R. Sterling,et al.  The on-line promotion and sale of nutrigenomic services , 2008, Genetics in Medicine.

[5]  A. Edgley ‘A Spoonful of Regulation Helps the Medicine Go Down’: The Changing Face of Medicine Regulation , 2007 .

[6]  R. Westrum The Social Construction of Technological Systems , 1989 .

[7]  Nancy Tomes,et al.  Merchants of Health: Medicine and Consumer Culture in the United States, 1900–1940 , 2001 .

[8]  M. Nichter,et al.  For my wellness, not just my illness: North Americans’ use of dietary supplements , 2006, Culture, medicine and psychiatry.

[9]  M. Khoury,et al.  Genomic profiling to promote a healthy lifestyle: not ready for prime time , 2003, Nature Genetics.

[10]  S. Woolgar Configuring the User: The Case of Usability Trials , 1990 .

[11]  A. Clarke,et al.  Biomedicalization: Technoscientific Transformations of Health, Illness, and U.S. Biomedicine , 2003, American Sociological Review.

[12]  Celia Lury,et al.  Global Nature, Global Culture , 2000 .

[13]  J. Lehenkari ON THE BORDERLINE OF FOOD AND DRUG: Constructing Credibility and Markets for a Functional Food Product , 2003 .

[14]  Katie J. Ward,et al.  The birth of the e-clinic. Continuity or transformation in the UK governance of pharmaceutical consumption? , 2005, Social science & medicine.

[15]  A. Harvey From genetic risk to post-genomic uncertainties: nutrigenomics and the birth of the “genetic entrepreneur” , 2009 .

[16]  D. Melzer,et al.  Genetic tests for common diseases: new insights, old concerns , 2008, BMJ : British Medical Journal.

[17]  M. Khoury,et al.  Genetics and genomics in practice: the continuum from genetic disease to genetic information in health and disease. , 2003 .

[18]  E. Einsiedel,et al.  Evaluating online direct-to-consumer marketing of genetic tests: informed choices or buyers beware? , 2008, Genetic testing.

[19]  W. Gamson,et al.  Media Discourse and Public Opinion on Nuclear Power: A Constructionist Approach , 1989, American Journal of Sociology.

[20]  Clare Williams,et al.  Ethical boundary-work in the embryonic stem cell laboratory. , 2006, Sociology of health & illness.

[21]  B. Glaser The Constant Comparative Method of Qualitative Analysis , 1965 .

[22]  A. Pollack The wide, wild world of genetic testing. , 2006, The New York times on the Web.

[23]  Sarah Nettleton,et al.  The Emergence of E-Scaped Medicine? , 2004 .

[24]  A. Clarke Situational Analysis: Grounded Theory After the Postmodern Turn , 2005 .

[25]  T. Bubela,et al.  Framing Nutrigenomics for Individual and Public Health: Public Representations of an Emerging Field , 2009 .

[26]  J. Law A Sociology of monsters: Essays on power, technology, and domination , 1991 .

[27]  T. Pinch,et al.  The Social Construction of Facts and Artefacts: or How the Sociology of Science and the Sociology of Technology might Benefit Each Other , 1984 .

[28]  J. Fishman,et al.  Manufacturing Desire: , 2004, Social Studies of Science.

[29]  E. Goffman Frame analysis: An essay on the organization of experience , 1974 .

[30]  Nikolas Rose,et al.  The Politics of Life Itself , 2001, The New Social Theory Reader.

[31]  D. Melzer,et al.  Genetics and medicalisation , 2002, BMJ : British Medical Journal.

[32]  T. Gieryn Boundary-work and the demarcation of science from non-science: Strains and interests in professional , 1983 .